Financial Metrics Check: Exact Sciences Corp. (EXAS)’s Ratios for Trailing Twelve Months

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Exact Sciences Corp.’s stock clocked out at $69.64, down -0.64% from its previous closing price of $70.09. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 1.65 million shares were traded. EXAS stock price reached its highest trading level at $71.13 during the session, while it also had its lowest trading level at $69.31.

Ratios:

To gain a deeper understanding of EXAS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.17. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $75.

On June 27, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $70.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 18 ’24 when Baranick Brian sold 929 shares for $70.00 per share. The transaction valued at 65,030 led to the insider holds 13,687 shares of the business.

Baranick Brian bought 929 shares of EXAS for $65,030 on Sep 18 ’24. On May 01 ’24, another insider, COWARD D SCOTT, who serves as the Director of the company, sold 67 shares for $60.15 each. As a result, the insider received 4,030 and left with 44,644 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 12867382272 and an Enterprise Value of 14704523264. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.93 while its Price-to-Book (P/B) ratio in mrq is 4.03. Its current Enterprise Value per Revenue stands at 5.63 whereas that against EBITDA is -213.415.

Stock Price History:

Over the past 52 weeks, EXAS has reached a high of $79.62, while it has fallen to a 52-week low of $40.62. The 50-Day Moving Average of the stock is 22.14%, while the 200-Day Moving Average is calculated to be 18.36%.

Shares Statistics:

It appears that EXAS traded 2.93M shares on average per day over the past three months and 3941670 shares per day over the past ten days. A total of 184.77M shares are outstanding, with a floating share count of 181.98M. Insiders hold about 1.51% of the company’s shares, while institutions hold 97.25% stake in the company. Shares short for EXAS as of 1724976000 were 14508256 with a Short Ratio of 4.95, compared to 1722384000 on 13592719. Therefore, it implies a Short% of Shares Outstanding of 14508256 and a Short% of Float of 7.93.

Most Popular